Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Mrpl53 | Mouse | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPL53 mRNA | CTD | PMID:22206623 | Mrpl53 | Mouse | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of MRPL53 mRNA | CTD | PMID:17942748 | Mrpl53 | Mouse | 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MRPL53 mRNA | CTD | PMID:17942748 | Mrpl53 | Mouse | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:31388691 | Mrpl53 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MRPL53 mRNA | CTD | PMID:17942748 | Mrpl53 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of MRPL53 mRNA | CTD | PMID:21570461 | Mrpl53 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Mrpl53 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MRPL53 mRNA | CTD | PMID:21215274 | Mrpl53 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Mrpl53 (Rattus norvegicus) | 6480464 | AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of MRPL53 mRNA] | CTD | PMID:21215274 | Mrpl53 | Mouse | 4,4'-diaminodiphenylmethane | decreases expression | EXP | | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of MRPL53 mRNA | CTD | PMID:18648102 | Mrpl53 | Mouse | 6-propyl-2-thiouracil | increases expression | ISO | Mrpl53 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of MRPL53 mRNA | CTD | PMID:30047161 | Mrpl53 | Mouse | aflatoxin B1 | increases methylation | ISO | MRPL53 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of MRPL53 gene | CTD | PMID:27153756 | Mrpl53 | Mouse | amitrole | increases expression | ISO | Mrpl53 (Rattus norvegicus) | 6480464 | Amitrole results in increased expression of MRPL53 mRNA | CTD | PMID:30047161 | Mrpl53 | Mouse | Aroclor 1254 | increases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of MRPL53 mRNA | CTD | PMID:23650126 | Mrpl53 | Mouse | arsenite(3-) | increases expression | EXP | | 6480464 | arsenite results in increased expression of MRPL53 protein | CTD | PMID:37955338 | Mrpl53 | Mouse | arsenite(3-) | multiple interactions | ISO | MRPL53 (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to MRPL53 mRNA] | CTD | PMID:32406909 | Mrpl53 | Mouse | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of MRPL53 mRNA | CTD | PMID:20504355 | Mrpl53 | Mouse | beta-lapachone | decreases expression | ISO | MRPL53 (Homo sapiens) | 6480464 | beta-lapachone results in decreased expression of MRPL53 mRNA | CTD | PMID:38218311 | Mrpl53 | Mouse | bisphenol A | increases expression | ISO | Mrpl53 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of MRPL53 mRNA | CTD | PMID:25181051 | Mrpl53 | Mouse | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MRPL53 mRNA | CTD | PMID:33221593 and PMID:38074096 | Mrpl53 | Mouse | cadmium dichloride | decreases expression | ISO | MRPL53 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of MRPL53 mRNA | CTD | PMID:38382870 | Mrpl53 | Mouse | choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MRPL53 gene | CTD | PMID:20938992 | Mrpl53 | Mouse | chromium(6+) | affects expression | EXP | | 6480464 | chromium hexavalent ion affects the expression of MRPL53 mRNA | CTD | PMID:28472532 | Mrpl53 | Mouse | clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of MRPL53 mRNA | CTD | PMID:17585979 | Mrpl53 | Mouse | clofibrate | multiple interactions | EXP | | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of MRPL53 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MRPL53 mRNA] | CTD | PMID:17585979 | Mrpl53 | Mouse | corosolic acid | decreases expression | ISO | MRPL53 (Homo sapiens) | 6480464 | corosolic acid results in decreased expression of MRPL53 mRNA | CTD | PMID:37939859 | Mrpl53 | Mouse | crocidolite asbestos | increases expression | ISO | MRPL53 (Homo sapiens) | 6480464 | Asbestos and Crocidolite results in increased expression of MRPL53 mRNA | CTD | PMID:29523930 | Mrpl53 | Mouse | fenthion | increases expression | EXP | | 6480464 | Fenthion results in increased expression of MRPL53 mRNA | CTD | PMID:34813904 | Mrpl53 | Mouse | finasteride | increases expression | ISO | Mrpl53 (Rattus norvegicus) | 6480464 | Finasteride results in increased expression of MRPL53 mRNA | CTD | PMID:24136188 | Mrpl53 | Mouse | flutamide | increases expression | ISO | Mrpl53 (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of MRPL53 mRNA | CTD | PMID:24136188 | Mrpl53 | Mouse | folic acid | multiple interactions | EXP | | 6480464 | [1 more ... | CTD | PMID:20938992 and PMID:22206623 | Mrpl53 | Mouse | hydralazine | multiple interactions | ISO | MRPL53 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of MRPL53 mRNA | CTD | PMID:17183730 | Mrpl53 | Mouse | hydrogen peroxide | affects expression | ISO | MRPL53 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of MRPL53 mRNA | CTD | PMID:21179406 | Mrpl53 | Mouse | ivermectin | decreases expression | ISO | MRPL53 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of MRPL53 protein | CTD | PMID:32959892 | Mrpl53 | Mouse | L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MRPL53 gene | CTD | PMID:20938992 | Mrpl53 | Mouse | lipopolysaccharide | multiple interactions | ISO | MRPL53 (Homo sapiens) | 6480464 | [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPL53 mRNA | CTD | PMID:31059760 | Mrpl53 | Mouse | lithium atom | multiple interactions | ISO | Mrpl53 (Rattus norvegicus) | 6480464 | Lithium inhibits the reaction [Methamphetamine results in increased expression of MRPL53 mRNA] | CTD | PMID:19149911 | Mrpl53 | Mouse | lithium hydride | multiple interactions | ISO | Mrpl53 (Rattus norvegicus) | 6480464 | Lithium inhibits the reaction [Methamphetamine results in increased expression of MRPL53 mRNA] | CTD | PMID:19149911 | Mrpl53 | Mouse | methamphetamine | multiple interactions | ISO | Mrpl53 (Rattus norvegicus) | 6480464 | Lithium inhibits the reaction [Methamphetamine results in increased expression of MRPL53 mRNA] | CTD | PMID:19149911 | Mrpl53 | Mouse | methamphetamine | increases expression | ISO | Mrpl53 (Rattus norvegicus) | 6480464 | Methamphetamine results in increased expression of MRPL53 mRNA | CTD | PMID:19149911 | Mrpl53 | Mouse | methidathion | increases expression | EXP | | 6480464 | methidathion results in increased expression of MRPL53 mRNA | CTD | PMID:34813904 | Mrpl53 | Mouse | methimazole | increases expression | ISO | Mrpl53 (Rattus norvegicus) | 6480464 | Methimazole results in increased expression of MRPL53 mRNA | CTD | PMID:30047161 | Mrpl53 | Mouse | nimesulide | increases expression | ISO | Mrpl53 (Rattus norvegicus) | 6480464 | nimesulide results in increased expression of MRPL53 mRNA | CTD | PMID:24136188 | Mrpl53 | Mouse | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MRPL53 mRNA | CTD | PMID:34911549 | Mrpl53 | Mouse | paracetamol | multiple interactions | EXP | | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of MRPL53 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MRPL53 mRNA] | CTD | PMID:17585979 | Mrpl53 | Mouse | paracetamol | decreases expression | ISO | MRPL53 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of MRPL53 mRNA | CTD | PMID:31059760 | Mrpl53 | Mouse | paracetamol | multiple interactions | ISO | MRPL53 (Homo sapiens) | 6480464 | [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPL53 mRNA | CTD | PMID:31059760 | Mrpl53 | Mouse | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of MRPL53 mRNA | CTD | PMID:17562736 | Mrpl53 | Mouse | perfluorooctanoic acid | increases expression | ISO | Mrpl53 (Rattus norvegicus) | 6480464 | perfluorooctanoic acid results in increased expression of MRPL53 protein | CTD | PMID:34958885 | Mrpl53 | Mouse | propiconazole | increases expression | ISO | Mrpl53 (Rattus norvegicus) | 6480464 | propiconazole results in increased expression of MRPL53 mRNA | CTD | PMID:30047161 | Mrpl53 | Mouse | sulfadimethoxine | increases expression | ISO | Mrpl53 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in increased expression of MRPL53 mRNA | CTD | PMID:30047161 | Mrpl53 | Mouse | sulforaphane | increases expression | ISO | MRPL53 (Homo sapiens) | 6480464 | sulforaphane results in increased expression of MRPL53 mRNA | CTD | PMID:31838189 | Mrpl53 | Mouse | sulindac | increases expression | ISO | Mrpl53 (Rattus norvegicus) | 6480464 | Sulindac results in increased expression of MRPL53 mRNA | CTD | PMID:24136188 | Mrpl53 | Mouse | titanium dioxide | decreases methylation | EXP | | 6480464 | titanium dioxide results in decreased methylation of MRPL53 gene and titanium dioxide results in decreased methylation of MRPL53 promoter | CTD | PMID:35295148 | Mrpl53 | Mouse | tolcapone | decreases expression | ISO | Mrpl53 (Rattus norvegicus) | 6480464 | tolcapone results in decreased expression of MRPL53 mRNA | CTD | PMID:24136188 | Mrpl53 | Mouse | toluene | decreases expression | ISO | Mrpl53 (Rattus norvegicus) | 6480464 | Toluene results in decreased expression of MRPL53 mRNA | CTD | PMID:22967744 | Mrpl53 | Mouse | valproic acid | multiple interactions | ISO | MRPL53 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of MRPL53 mRNA | CTD | PMID:17183730 | Mrpl53 | Mouse | valproic acid | affects expression | ISO | MRPL53 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of MRPL53 mRNA | CTD | PMID:25979313 | |